FOCUS follow up of clinical outcomes: the long-term AGI-1067 [succinobucol] plus usual care study

Trial Profile

FOCUS follow up of clinical outcomes: the long-term AGI-1067 [succinobucol] plus usual care study

Discontinued
Phase of Trial: Phase III

Latest Information Update: 02 Jun 2011

At a glance

  • Drugs Succinobucol (Primary)
  • Indications Coronary artery disease
  • Focus Registrational; Therapeutic Use
  • Acronyms FOCUS
  • Sponsors AtheroGenics
  • Most Recent Events

    • 14 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top